Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics Inc. | Chief Scientific Officer | $1.37M | Mar 29, 2022 | ||
ACRV | Acrivon Therapeutics, Inc. | Director | Jun 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|